Skip to main content
. 2020 Aug 12;12:246. doi: 10.3389/fnagi.2020.00246

Table 2.

Neuropsychological tests of presbycusis patients and healthy controls.

Presbycusis patients (n = 40) Healthy controls (n = 40) p-value ES
MMSE 29.18 ± 1.06 28.68 ± 1.44 0.081 0.40
MoCA 25.68 ± 1.69 25.93 ± 1.79 0.522 0.14
AVLT 35.35 ± 7.38 34.88 ± 7.75 0.779 0.06
AVLT-delay 7.18 ± 2.23 6.75 ± 2.31 0.405 0.19
CFT 34.70 ± 1.57 34.58 ± 1.56 0.722 0.08
CFT-delay 16.70 ± 3.07 17.20 ± 2.78 0.447 0.17
TMT-A 70.73 ± 21.56 67.60 ± 18.36 0.487 0.16
TMT-B 195.73 ± 63.59 156.03 ± 53.52 0.003* 0.68
CDT 3.55 ± 0.55 3.63 ± 0.54 0.541 0.15
DST 10.65 ± 1.48 11.68 ± 2.08 0.013* 0.57
VFT 13.95 ± 4.05 14.41 ± 3.71 0.596 0.12
DSST 70.13 ± 8.22 68.73 ± 9.94 0.494 0.15
SAS 36.83 ± 5.82 36.38 ± 6.04 0.735 0.08
SDS 39.03 ± 9.24 37.13 ± 8.45 0.340 0.21

Data are represented as Mean ± SD, *p < 0.05. MMSE, Mini-Mental State Exam; MoCA, Montreal Cognitive Assessment; AVLT, Auditory Verbal Learning Test; CFT, Complex Figure Test; DST, Digit Span Test. TMT-A, Trail Making Test-Part A; TMT-B, Trail Making Test-Part B; CDT, Clock Drawing Test; VFT, Verbal Fluency Test; DSST, Digit Symbol Substitution Test; SDS, Self-Rating Depression Scale; SAS, Self-Rating Anxiety Scale; ES, effect size.